The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFederico II University
About this trial
The aim this prospective observational study is to evaluate the role of Indocyanine Green Fluorescence (ICG) in patients with achalasia underwent to Heller-Dor laparoscopic. The main gol are:
* If with use of ICG iatrogenic mucosal leaks can be identified and, if necessary, improve the myotomy. * Assess the need for postoperative radiographic control using esophagogastric radiography with gastrografin. * Compare clinical characteristics, perioperative outcomes, and 12-month postoperative follow-up between the two populations.
Eligibility criteria
Qualifiers
patients with achalasia of type I and II
patients undergoing laparoscopic Heller-Dor
patients older than 18 years
Disqualifiers
Patients <18 years of age;
Uncooperative patients and/or patients unable to provide informed consent
ASA ≥4
BMI ≥30
Trial design
Treatments tested in this trial
- Not listed
Trial groups
70 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov